Xlife Sciences AG (SWX:XLS)
Switzerland · Delayed Price · Currency is CHF 8.30
-0.30 (-3.49%)
At close: Nov 10, 2026
Xlife Sciences AG Market Cap
Xlife Sciences AG has a market cap or net worth of 47.87 million as of November 10, 2026. It is the 28,846th most valuable company in the world and the 194th biggest in Switzerland. Its market cap has decreased by 53.89% in one year.
Market Cap
47.87M
Enterprise Value
188.19M
Revenue
397.23K
Global Rank
Country Rank
#194 Switzerland
PE Ratio
n/a
ChartMarket Cap Chart
Since February 10, 2022, Xlife Sciences AG's market cap has decreased from 240.46M to 47.87M, a decrease of -80.09%. That is a compound annual growth rate of -28.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 47.87M | -66.40% |
| Dec 30, 2025 | 142.46M | -2.32% |
| Dec 30, 2024 | 145.84M | -47.72% |
| Dec 29, 2023 | 278.96M | 77.76% |
| Dec 30, 2022 | 156.93M | -34.74% |
| Feb 10, 2022 | 240.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bachem Holding AG | 5.97B |
| Idorsia | 1.09B |
| Basilea Pharmaceutica AG | 882.25M |
| Santhera Pharmaceuticals Holding AG | 228.38M |
| Newron Pharmaceuticals | 187.54M |
| BioVersys AG | 131.38M |
| Molecular Partners AG | 99.67M |
| MindMaze Therapeutics Holding | 22.81M |